Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2

Inflammopharmacology. 2022 Oct;30(5):1541-1553. doi: 10.1007/s10787-022-01037-4. Epub 2022 Jul 26.

Abstract

The emergence of pathogenic viruses is a worldwide frequent cause of diseases and, therefore, the design of treatments for viral infections stands as a significant research topic. Despite many efforts, the production of vaccines is faced with many obstacles and the high rate of viral resistance caused a severe reduction in the efficacy of antiviral drugs. However, the attempt of developing novel natural drugs, as well as the exertion of medicinal plants, may be an applicable solution for the treatment of viral diseases. Boswellia species exhibited a wide range of pharmacological activities in various conditions such as bronchial asthma, rheumatism, and Crohn's illness. Additionally, pharmacological studies reported the observance of practical antiviral activities from different parts of this substance, especially the oleo-gum-resin. Therefore, this work provided an overview on the antiviral properties of Boswellia species and their potential therapeutic effects in the field of COVID-19 pandemic.

Keywords: Antiviral effect; Boswellia species; Herbal medicine; Natural therapies; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Boswellia*
  • COVID-19 Drug Treatment*
  • Humans
  • Pandemics
  • SARS-CoV-2

Substances

  • Antiviral Agents